ACTONEL cpr 35 mg gastro-résistantes 12 pce

7680691440021 CH-69144 M05BA07 07.99.0.

Reimbursement limitations:

ACTONEL.01

Pour le traitement de l'ostéoporose documentée.

ACTONEL cpr 35 mg gastro-résistantes 12 pce
ACTONEL cpr 35 mg gastro-résistantes 12 pce
ACTONEL cpr 35 mg gastro-résistantes 12 pce
1 / 3
google

Details

Product number
6914401
CPT
-
Packaging group
12
Unit
Tablette(n)
Composition
natrii risedronas 35.0 mg corresp. risedronas 32.48 mg, cellulosum microcristallinum silicificatum, dinatrii edetas, carboxymethylamylum natricum A, acidum stearicum, magnesii stearas, Überzug: acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, triethylis citras, talcum, E 172 (flavum), simeticonum, polysorbatum 80, pro compresso obducto corresp. natrium 16.64 mg.

Articles (1)

Actonel 35 mg, magensaftresistente Tabletten
Magensaftresistente Tabletten
12
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/07/2024
Patient information leaflet
Français
29/07/2024
Patient information leaflet
Italien
29/07/2024
Professional SmPC
Allemand
29/07/2024
Professional SmPC
Français
29/07/2024
Professional SmPC
Italien
29/07/2024

Detailed composition

Substance Quantity Type Category
(N/A)
35.0 MG Substance WIZUS
(N/A)
32.48 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
16.64 MG Substance HBESI

Reimbursement information

Public price
CHF 63.75
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2024

Authorization holder

Future Health Pharma GmbH

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
69144
Drug name
Actonel, magensaftresistente Tabletten
Galenic form
MATB
ATC Code
M05BA07
Authorization status
Z
Dispensation category
B
First authorization
14/02/2024
Authorization expiration date
13/02/2029
IT number
07.99.0.
Domain
Human medicine
Field of application
Behandlung der Osteoporose bei postmenopausalen Frauen mit erhöhtem Frakturrisiko

Packaging details

Description (FR)
ACTONEL cpr 35 mg gastro-résistantes 12 pce
Description (DE)
ACTONEL Tabl 35 mg magensaftresistent 12 Stk
Market launch
14/02/2024
Narcotic (BTM)
No

Other packaging sizes

ACTONEL cpr 35 mg gastro-résistantes 4 pce
4 TABL
View